Systematic (IUPAC) name | |
---|---|
5-benzyl-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole | |
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Pregnancy cat. | Not established[1] |
Legal status | ? |
Routes | oral[1] |
Identifiers | |
CAS number | 524-81-2 6153-33-9[2] |
ATC code | R06AX15 |
PubChem | CID 22530 |
ChemSpider | 21129 |
UNII | 9SUK9B7XVY |
KEGG | D08161 |
Synonyms | 9-Benzyl-2-methyl-2,3,4,9-tetrahydro-1H-β-carboline, Incidal, Omeril, diazolin, Fabahistin, mebhydrolin napadisylate, mebhydroline 1,5-naphthalenedisulfonate[3] |
Chemical data | |
Formula | C19H20N2[4] |
Mol. mass | 276.376 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Mebhydrolin (INN) or mebhydroline is an antihistamine. It is not available in the United States, but it is in various other countries. It is also called Bexidal (BD) and Diazolin (RU). It is used for symptomatic relief of allergic symptoms caused by histamine release, including nasal allergies and allergic dermatosis.
Mebhydrolin has been shown to enhance the performance-deficit effects of alcohol.[5]
|